1999
DOI: 10.1076/1388-0209(200010)37:sup;1-w;ft005
|View full text |Cite
|
Sign up to set email alerts
|

Preface Drug Discovery, Economic Development And Conservation: The International Cooperative Biodiversity Groups

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
16
0
1

Year Published

2004
2004
2021
2021

Publication Types

Select...
5
4

Relationship

1
8

Authors

Journals

citations
Cited by 18 publications
(17 citation statements)
references
References 0 publications
0
16
0
1
Order By: Relevance
“…From 1989 to 1995, over 60% of approved drugs and pre-NDA candidates in these disease areas were from natural products (Cragg et al, 1997). While natural products drug discovery efforts increasingly focus more on micro-organisms and fungi, research continues with vascular plants and much of this work is in areas of high biodiversity and endemism such as the humid tropics (Rosenthal, 1997).…”
Section: Introductionmentioning
confidence: 99%
“…From 1989 to 1995, over 60% of approved drugs and pre-NDA candidates in these disease areas were from natural products (Cragg et al, 1997). While natural products drug discovery efforts increasingly focus more on micro-organisms and fungi, research continues with vascular plants and much of this work is in areas of high biodiversity and endemism such as the humid tropics (Rosenthal, 1997).…”
Section: Introductionmentioning
confidence: 99%
“…A complete review of the ICBGs has been published (Rosenthal and Pezzuto, 1999). The University of Illinois at Chicago (UIC)-based ICBG, known simply as "UIC ICBG" or "Studies on Biodiversity of Vietnam and Laos" (Soejarto et al, 1999(Soejarto et al, ,b, 2004a, serves as a model for the implementation of the ICBG principles, which are, ultimately, the principles of the United Nations Convention on Biological Diversity.…”
Section: "Studies On Biodiversity Of Vietnam and Laos": An Icbg Progrmentioning
confidence: 99%
“…The implementation of this program is based on the belief that the discovery and development of pharmaceutical and other useful agents from the world's biodiversity can, under appropriate circumstances, promote scientific capacity development and economic incentives to conserve the biological resources from which these products are derived (Fogarty International Center, 2004). This unique effort is undertaken in such a way that local communities and other source country organizations can derive direct benefits from the effort and, ultimately, from their diverse biological resources, so that benefit-sharing may provide clear incentives for preservation and sustainable use of the biodiversity (Rosenthal, 1996(Rosenthal, , 1997Fogarty International Center, 2004).…”
Section: Mass Bioprospecting: Contemporary Modelsmentioning
confidence: 99%
“…The program has completed two 5-year cycles with eight (8) cooperative groups being funded over the first (1993-94) and second (1997) round of awards. These projects have been described in detail in a special publication [19]. A third round of awards is in mid cycle, including 4 new groups.…”
Section: Program III International Cooperative Biodiversity Groups (mentioning
confidence: 99%